Furthermore, we demonstrated that high ANXA2 and ANXA4 expression predicted poor survival in patients with cervical cancer, which was supported by the improved predictive power of a model using combined clinical-ANXA2/ANXA4-variables. Here, ANXA2 is linked to cervical carcinoma.